By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155




Company News
Aegerion (AEGR), A Subsidiary Of Novelion (AEGR), Enters Into Agreement In Principle To Settle Class Action Shareholder Lawsuit 12/5/2016 8:10:39 AM
Veristat Strengthens Its Long-Standing Relationship With Aegerion (AEGR) By Establishing A Preferred Provider Agreement 9/19/2016 10:29:49 AM
Aegerion (AEGR) Announces Second Quarter 2016 Financial Results 8/10/2016 8:05:48 AM
Struggling Aegerion (AEGR) Axes 13% of Workforce, Withdraws Cholesterol Drug from the EU 7/21/2016 6:41:01 AM
Update In Lawsuit For Investors In Aegerion (AEGR) Shares Announced By Shareholders Foundation 6/21/2016 8:10:19 AM
Aegerion (AEGR) CEO on Company's Long Road and Its Fresh Start Post-Merger 6/17/2016 6:05:22 AM
Beleaguered Cambridge Drugmaker Aegerion (AEGR) Merges with QLT (QLTI) to Survive 6/15/2016 6:21:45 AM
Aegerion (AEGR) Announces First Quarter 2016 Financial Results 5/17/2016 8:47:01 AM
Aegerion (AEGR) Observes Rare Disease Day 2/29/2016 7:52:16 AM
Aegerion (AEGR) Announces Fourth Quarter And Full Year 2015 Financial Results 2/26/2016 8:02:15 AM